在重症监护中先进的机器辅助肝脏康复
Yaroslava Longhitano1, Giorgia Caputo2, Michela Colella Bisogno3
1Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh, Pittsburgh, PA, USA.
Journal of intensive care medicine
|December 23, 2025
概括
机器输液 (MP) 技术为肝移植提供了更好的保存,减少缺血-再输液损伤 (IRI),并使更多的捐赠器官能够使用. 常温机器输液 (NMP) 显示了对移植评估和延长保存的前景.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 生物医学工程 生物医学工程
背景情况:
- 肝移植 (LT) 面临的挑战是缺血-再输液损伤 (IRI) 和供体器官短缺.
- 从扩展标准捐赠者 (ECD) 和循环死亡后捐赠 (DCD) 的边缘移植越来越多地使用,但更容易受到IRI的影响.
研究的目的:
- 审查机器输液 (MP) 技术,以保护和利用在LT.肝脏移植.
- 与静态冷藏 (SCS) 相比,评估低温,低温和高温的MP.
主要方法:
- 对肝移植 (LT) 中机器输液 (MP) 技术的当前文献的综述.
- 低温机器输液 (HMP),有氧化HMP (HOPE),低温机器输液和高温机器输液 (NMP) 的评估.
主要成果:
- 希望显示对胆道系统的保护作用,并可能减少缺血性损伤.
- 在临床试验中,常温机器输液 (NMP) 表明早期全移植功能障碍减少,边缘移植的使用增加.
- 像HOPE这样的组合技术,其次是NMP,可能会带来协同效益.
结论:
- 机器输液 (MP) 技术代表了肝移植 (LT) 的重大进步.
- 对于功能评估和延长保存,NMP是有前途的,而HOPE对于恢复有价值.
- 需要进一步的大规模试验来确定MP作为标准的LT协议.
关键词:
在循环死亡后的捐赠.扩展标准 捐助者 捐赠者缺血-再输液损伤 缺血-再输液损伤肝脏移植 肝脏移植 肝脏移植 肝脏移植perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion perfusion 这是一个非常重要的方法,它可以让一个人觉得自己是个好的人,而不是一个好的人,而是一个好的人.重新修复的情况.相关概念视频
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
420
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
420
Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Continuous Renal Replacement Therapy
2.4K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.4K


